These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2257872)

  • 61. Effect of intra-individual change in serum protein binding on the pharmacologic response of R- and S-disopyramide in the rabbit.
    Huang JD; Oie S
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):243-53. PubMed ID: 6635319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.
    Pratt CM; Young JB; Francis MJ; Taylor AA; Norton HJ; English L; Mann DE; Kopelen H; Quinones MA; Roberts R
    Circulation; 1984 Feb; 69(2):288-97. PubMed ID: 6360413
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of disopyramide on left ventricular performance: the relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.
    Holt GW; Norris RL; Ravenscroft PJ; Bett JH; Dryburgh LG; Boyle CM
    J Cardiovasc Pharmacol; 1983; 5(1):51-4. PubMed ID: 6186859
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of phenytoin on serum disopyramide concentrations.
    Nightingale J; Nappi JM
    Clin Pharm; 1987 Jan; 6(1):46-50. PubMed ID: 3816106
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical pharmacokinetics and effects of an oral sustained-release preparation of disopyramide prescribed for patients undergoing maintenance hemodialysis.
    Kaji T; Nojima Y; Arisaka H; Naruse T
    Blood Purif; 2000; 18(1):55-8. PubMed ID: 10686443
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double-blind atropine trial for active learning of autonomic function.
    Fry JR; Burr SA
    Adv Physiol Educ; 2011 Dec; 35(4):438-44. PubMed ID: 22139783
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The anticholinergic side effects of disopyramide and controlled-release disopyramide.
    Teichman S
    Angiology; 1985 Nov; 36(11):767-71. PubMed ID: 4061965
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transfer from immediate-release disopyramide to controlled-release disopyramide.
    DiPersio DM; Chow MS
    Angiology; 1987 Feb; 38(2 Pt 2):188-91. PubMed ID: 3103493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers.
    Szabadi E; Gaszner P; Bradshaw CM
    Br J Psychiatry; 1980 Nov; 137():433-9. PubMed ID: 7470769
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mechanism of cibenzoline-induced anticholinergic action in single atrial myocytes: comparison with effect of disopyramide.
    Wu SN; Nakajima T; Yamashita T; Hamada E; Hazama H; Iwasawa K; Omata M; Kurachi Y
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):618-23. PubMed ID: 7516012
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiarrhythmic and electrocardiographic effects of single oral doses of disopyramide.
    Hulting J; Jansson B
    Eur J Clin Pharmacol; 1977 Jan; 11(2):91-9. PubMed ID: 320015
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole].
    Fechter P; Nager F
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1897-900. PubMed ID: 6187065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and tolerance of trospium chloride in the high dose range.
    Breuel HP; Mürtz G; Bondy S; Horkulak J; Gianetti BM
    Arzneimittelforschung; 1993 Apr; 43(4):461-4. PubMed ID: 8494577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Saliva concentrations of disopyramide cannot substitute the drug's plasma concentrations.
    Cordonnier J; Van den Heede M; Heyndrickx A
    J Anal Toxicol; 1987; 11(4):179-81. PubMed ID: 3626531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the parasympatholytic activity of ACC-9358 and disopyramide.
    Brown BS; Gorczynski RJ; Reynolds RD; Shaffer JE
    Br J Pharmacol; 1986 Jan; 87(1):87-95. PubMed ID: 3513881
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing.
    Della Bella P; Tondo C; Marenzi G; Cipolla CM; Doni F; Grazi S; Rimondini A; Salvioni A; Guazzi MD
    Am J Cardiol; 1988 May; 61(13):1046-9. PubMed ID: 3284318
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias.
    Fechter P; Ha HR; Follath F; Nager F
    Eur J Clin Pharmacol; 1983; 25(6):729-34. PubMed ID: 6662171
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.
    Cunningham JL; Shen DD; Shudo I; Azarnoff DL
    Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancement of the antiarrhythmic action of disopyramide by digoxin.
    García-Barreto D; Groning E; González-Gómez A; Pérez A; Hernández-Cañero A; Toruncha A
    J Cardiovasc Pharmacol; 1981; 3(6):1236-42. PubMed ID: 6173523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.